REGISTER NOW

 

APRIL 21-23, 2020

BOSTON, MA USA

Speaking Faculty

Please check back in the coming weeks for updates to this list or join our mailing list HERE 

Conference Chair

Mollie Roth, J.D.

Executive Director
The Microbiome Coalition (TMBC)

 

  

2019 Speaking Faculty

    • Shahram Lavasani, Ph.D.

    • Founder, CEO/CSO
    • Immune Biotech

Olle_Bernat.jpg

    • Scott Jackson, Ph.D.

    • Group Leader, Complex Microbial Systems
    • NIST (National Institute of Standards & Technology)

Solomon_Jeffrey.png

    • Rachel Clemens, Ph.D.

    • Commercial Innovation Manager, Life Science Lead
    • ISS US National Lab, Center for Advancement in Science in Space

Smith_Mark1.jpg

    • Lynne Elmore, Ph.D.

    • Director, Translational Cancer Research Program
    • American Cancer Society

    • Garth Ehrlich, Ph.D.

    • Professor of Microbiology & Immunology, Professor of Otolayngology - Head & Neck Surgery
    • Drexel University College of Medicine

Olle_Bernat.jpg

    • Momo Vuyisich, Ph.D.

    • Chief Scientific Officer
    • Viome

Solomon_Jeffrey.png

    • Nancy Caralla

    • Foundiing President, Executive Director
    • C Diff Foundation

Smith_Mark1.jpg

    • Rachel Teitelbaum, Ph.D.

    • Chief Executive Officer
    • Hervana

    • Sonia Timberlake, Ph.D.

    • Vice President of Research
    • Finch Therapeutics

Olle_Bernat.jpg

    • Dae-Wook Kang, Ph.D.

    • Assistant Professor, Department of Civil & Environmental Engineering
    • University of Toledo

Solomon_Jeffrey.png

    • Sangeeta Khare, Ph.D.

    • Research Microbiologist, Division of Microbiology, National Center for Toxicological Research
    • US Food & Drug Administration

Smith_Mark1.jpg

    • Amy Feehan, Ph.D.

    • Research Scientist
    • Ochsner Health System

    • Julius Goepp, MD

    • Chief Executive Officer
    • Scaled Microbiomics

Olle_Bernat.jpg

    • Ze'ev Ronai, Ph.D.

    • Professor
    • Sanford Burnham Prebys Medical Discovery Institute

Solomon_Jeffrey.png

    • Henrik Bjorn Nielsen, Ph.D.

    • Chief Scientific Officer
    • Clinical Microbiomics

Solomon_Jeffrey.png

    • Steve Schnittger

    • VP Global Microbiology R&D
    • Estee Lauder

    • Lionel Breton, Ph.D., DSc

    • Scientific Director, L'Oreal Advanced Research
    • L'Oreal

Olle_Bernat.jpg

    • Anandh Babu Pon Velayutham, Ph.D.

    • Associate Professor, Nutrition & Integrative Physiology
    • University of Utah

Solomon_Jeffrey.png

    • Sara Ferrando Martinez, Ph.D.

    • Research Scientist
    • AstraZeneca

Solomon_Jeffrey.png

    • A. Stewart Campbell, Ph.D.

    • Vice President, Early Stage Development
    • Axial Biotherapeutics

    • Gregg Silverman, MD

    • Professor of Medicine & Pathology
    • New York University School of Medicine

Olle_Bernat.jpg

    • Henry Haiser, Ph.D.

    • Associate Scientific Director, GI Drug Discovery, Microbiome Sciences
    • Takeda

Olle_Bernat.jpg

    • Mahmoud Ghannoum, Ph.D., EMBA

    • Professor, Department of Dematology
    • Case Western Reserve University and University Hospitals Cleveland Medical Center

Olle_Bernat.jpg

    • Pamela Silver, Ph.D.

    • Elliot T. and Onie H. Adams Professor of Biochemistry and Systems Biology
    • Harvard Medical School

    • Danish Malik, Ph.D.

    • Senior Lecturer, Chemical Engineering Department
    • Loughborough University

Olle_Bernat.jpg

    • Assaf Oron

    • Chief Business Officer
    • BiomX

Olle_Bernat.jpg

    • Sebastien Guery, Ph.D., Pharm.D.

    • Human Microbiome Venture Leader
    • Dupont Nutrition and Health

Olle_Bernat.jpg

    • Paul Turner, Ph.D.

    • Rachel Carson Professor of Ecology & Evolutionary Biology
    • Yale University

    • Manoj Dadlani

    • Chief Executive Officer
    • Cosmos ID

Olle_Bernat.jpg

    • Barbara Rehermann, MD

    • Section Chief: Immunology Section, Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases
    • National Institutes of Health

Olle_Bernat.jpg

    • Michal Daniely, Ph.D.

    • Research and Development Director
    • Millipore Sigma

Olle_Bernat.jpg

    • Peter Christey, Ph.D.

    • CEO and Co-Founder
    • General Automation Technology Labs (GALT)

    • Gokul Swaminathan, Ph.D.

    • Associate Principal Scientist
    • Merck Exploratory Science Center

Olle_Bernat.jpg

    • Sam Minot, Ph.D.

    • Staff Scientist, Microbiome Research Initiative, Vaccine & Infectious Disease Division
    • Fred Hutchinson Cancer Center

Olle_Bernat.jpg

    • Nick Greenfield

    • Founder & CEO
    • One Codex

Olle_Bernat.jpg

    • Donna Boston

    • Program Manager
    • Div. of Research, Innovation & Ventures (DRIVe), Biomedical Advanced R&D Authority (BARDA), Assist. Sec. for Preparedness & Response (ASPR) US Dept. of Health & Human Services (HHS)

About Us

Our events give attendees a conference experience that encompasses learning, networking and professional growth. We strive to facilitate connections. At our events, attendees, speakers, sponsors and exhibitors have opportunities to network and then to utilize those connections to further their professional goals. At Arrowhead Publishers, our focus is on bringing life sciences industry professionals together to help move research forward. Learn more about us at www.arrowheadpublishers.com.

Contact Us

Arrowhead Publishers & Conferences
PO Box 96
7730 Laredo Drive, #96
Chanhassen, MN 55317
866-945-0263
enquiries@arrowheadpublishers.com

PRIVACY POLICY

Continuing Medical Education Credits Now Available for this Event

Joint-Providership Accreditation and Designation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Office of Continuing Medical Education of the University of Virginia School of Medicine and Arrowhead Publishers. The Office of Continuing Medical Education of the University of Virginia School of Medicine is accredited by the ACCME to provide continuing medical education for physicians

The University of Virginia School of Medicine designates this live activity for a maximum of 8 AMA PRA Category 1 Credits.TM Physicians should claim only the credit commensurate with the extent of their participation in the activity. (The number of credits offered for this event is subject to change dependent upon future additions/revisions to the agenda.)

The University of Virginia School of Medicine, as accredited provider, awards 8 hours of participation (consistent with the designated number of AMA PRA Category 1 Credit(s)TM ) to a participant who successfully completes this educational activity. The University of Virginia School of Medicine maintains a record of participation for six (6) years.

Shahram Lavasani, Ph.D.

Founder, Chief Executive Officer and Chief Scientific Officer
Immune Biotech

Profile coming soon.

Scott Jackson, Ph.D.

Group Leader, Complex Microbial Systems
NIST (National Institute of Standards & Technology

Profile coming soon.

Rachel Clemens, Ph.D.

Commerical Innovation Manager, Life Science Lead
ISS US National Lab, Center for Advancement in Science in Space

Profile coming soon.

Lynne Elmore, Ph.D.

Director, Translational Cancer Research Program
American Cancer Society

Lynne Elmore, PhD, is the director of the Translational Cancer Research program in the Extramural Grants department of the American Cancer Society (ACS). She manages a research portfolio focused on cell biology, infectious disease, the microbiome, molecular genetics, and cancer drug discovery.

Garth Ehrlich, Ph.D.

Professor of Microbiology & Immunology, Professor of Otolayngology - Head & Neck Surgery
Drexel University College of Medicine

Dr Ehrlich is Professor of Microbiology and Immunology, and Otolaryngology-Head and Neck Surgery at Drexel University College of Medicine (DUCOM) in Philadelphia, PA, USA. Dr. Ehrlich is also the founder and director of three Research Centers of Excellence in the Institute for Molecular Medicine and Infectious Disease: the Center for Genomic Sciences (CGS); the Center for Advanced Microbial Processing (CAMP); and the Center for Surgical Infections and Biofilms.

He also directs Drexel University’s Core Genomics Facility and the Meta-Omics Shared Resource for the Sidney Kimmel Cancer Center – an NCI-designated Cancer Center.

Momo Vuyisich, Ph.D.

Chief Scientific Officer
Viome

Momo Vuyisich is a co-founder and Chief Science Officer at Viome, a data-driven personalized nutrition company. Momo provides scientific leadership at Viome and his vision is to revolutionize healthcare from "symptoms management" to a true preventative medicine. He leads product development, clinical test implementation, and comprehensive clinical research portfolio.

Momo is also an Adjunct Professor at the University of New Mexico and New Mexico Tech. Before co-founding Viome in 2016, Momo spent 12 years at Los Alamos National Laboratory, where he led the Applied Genomics team, which developed the core technology used by Viome today.

Nancy Caralla

Founding President, Executive Director
C Diff Foundation

Nancy C Caralla is a three-time Clostridioides difficile infection (CDI) survivor. She has accumulated over 25 years of experience in the nursing profession blended with over 30 years in international construction management. Over the past several years, Nancy, in partnership with C Diff Foundation members, has focused on raising C. difficile awareness through education and advocating for Clostridium difficile infection prevention, treatments, clinical trials, AMR, and environmental safety worldwide. The C Diff Foundation is a non-profit organization that takes great pride in its volunteers, chairpersons, and committees.

Rachel Teitelbaum, Ph.D.

Chief Executive Officer
Hervana

Profile coming soon.

Sonia Timerlake, Ph.D.

Vice President of Research
Finch Therapeutics

Dr. Sonia Timberlake is the VP of Research at Finch Therapeutics, a microbiome therapeutics company. Sonia is an expert at designing NGS-based algorithms for applications in microbial genomics, immunogenomics, and evolution. Prior to joining Finch, she built and managed AbVitro's computational algorithms and infrastructure, supporting high throughput single-cell immune phenotyping and repertoire sequencing technology. This technology platform was acquired by Juno Therapeutics, where Sonia led a multidisciplinary team to harness native adaptive immune responses for developing engineered cell therapies in oncology.

Dae-Wook Kang, Ph.D.

Assistant Professor, Department of Civil & Environmental Engineering
University of Toledo

Profile coming soon.

Sameer Sonkusale, Ph.D.

Prof. of Electrical & Computer Engineering, Prof. of Biomedical Engineering (adjunct), Director/Principal Investigator, Nano Lab
Tufts University

Profile coming soon.

Amy Feehan, Ph.D.

Research Scientist
Ochsner Health System

Dr. Feehan is an early stage investigator who received her BS and PhD in Neuroscience from The Brain Institute at Tulane University in New Orleans. She has conducted research in humans and rodents covering topics ranging from drug development of novel endomorphin analogs for pain, to sleep and circadian rhythms research and most recently the gut-brain axis and infectious disease. Her doctoral work led to two patents for a compound that reverses both acute and chronic pain with no observable risk of addiction. She currently works as a research scientist in the Infectious Disease department at Ochsner in New Orleans designing and executing investigator-initiated clinical trials.